• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Concentric Medical Inc.

Aegea Medical picks up former Cardiokinetix, Concentric Medical CEO Sainz | Personnel Moves – May 14, 2018

May 14, 2018 By Fink Densford

Aegea Medical said last week it tapped former Cardiokinetix prez & CEO Maria Sainz as its new president and chief executive officer, effective immediately. Sainz will replace former CEO Don Gurskis, who has held the corner office since 2013. Gurskis will remain on as member of the Redwood City, Calif.-based company’s executive management team. “Maria is […]

Filed Under: Business/Financial News Tagged With: ACell, aegeamedical, Boston Scientific, Cardiac Dimensions Inc., CardioKinetix Inc., cellectbiotechnology, Cerus Corp., Concentric Medical Inc., Conventus Orthopaedics, Cordis Corp., Covidien, GE Healthcare, Guidant Corp., Hillrom, InfraReDx Inc., Nellix Inc., Nipro, Personnel Moves, sciton, Sensus Healthcare LLC, Stryker, Viveve Medical

Stryker gains on Q4 prelims

January 11, 2017 By Sarah Faulkner

Stryker (NYSE:SYK) shares are up after the orthopedics and hospital equipment giant posted preliminary financial results for the 4th quarter that narrowly beat the consensus forecast on Wall Street. The Kalamazoo, Mich.-based company said it expects a total revenue of $3.2 billion for Q4, up 16.3% from the same time last year. Analysts were looking for sales […]

Filed Under: Surgical Robotics, Vascular, Wall Street Beat Tagged With: Concentric Medical Inc., Stryker

Stryker’s Concentric Medical wins Class II FDA label for Trevo clot retrieval devices

December 27, 2016 By Fink Densford

The FDA today announced it has relabelled Stryker (NYSE:SYK) subsidiary Concentric Medical‘s Trevo mechanical thrombectomy devices as Class II. Concentric Medical submitted a request for reclassification of the Trevo ProVe and XP ProVue retrievers in October last year, according to the FDA. The federal watchdog reviewed the order, and said that on September 2 it issued an order […]

Filed Under: Food & Drug Administration (FDA), Regulatory/Compliance, Vascular Tagged With: Concentric Medical Inc., Stryker

FDA approves Concentric Medical’s Trevo clot retrievers

September 2, 2016 By Fink Densford

UPDATED Sept. 7, 2016, with comment from Stryker The FDA said today that it granted expanded approval to 2 of Stryker (NYSE:SYK) subsidiary Concentric Medical‘s Trevo clot retrieval devices, with new indications as initial therapy for strokes due to blood clots to reduce paralysis, speech difficulties and other stroke disabilities. The indications expand previous clearances for the devices, […]

Filed Under: Blood Management, Catheters, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: Concentric Medical Inc., Stryker

Telemedicine and the moon landing | MassDevice.com On Call

May 25, 2012 By MassDevice staff Leave a Comment

MassDevice On Call

MASSDEVICE ON CALL — Telemedicine may look like a future technology, but NASA has been using it to handle astronaut health care since the 1960s.

In a brief presentation at this year’s TEDMED conference, host Jay Walker told the audience how the 1st men who walked on the moon were wired with telemetric sensors that were monitored by mission control back on Earth.

Filed Under: News Well Tagged With: AdvaMed, Clinical Trials, Concentric Medical Inc., Mass. Institute of Technology, NASA, On Call, Remote Patient Monitoring, Stryker, Sunshine Laws

Covidien touts FDA clearance for “game-changing” Solitaire revascularization device

March 5, 2012 By MassDevice staff Leave a Comment

Soltaire FR device

Covidien plc (NYSE:COV) won FDA clearance for its Solitaire FR revascularization device for removing blood clots and restoring blood flow in the brains of patients suffering acute ischemic stroke.

The federal watchdog agency cleared the device, which physically removes blood clots from vessels, on the basis of data gathered during Covidien’s Swift study, the first of its kind to compare mechanical interventions for acute ischemic stroke, according to a press release.

Filed Under: News Well, Vascular Tagged With: Concentric Medical Inc., Covidien, ev3 Inc., Stryker

Stryker: Acquisitions helped boost top, bottom lines

January 25, 2012 By MassDevice staff Leave a Comment

Stryker logo

Although it posted healthy sales and profit growth last year, Stryker Corp. (NYSE:SYK) was a penny shy of analysts’ forecasts for adjusted earnings per share, which usually sends investors into a selling spree.

But the Kalamazoo, Mich.-based device maker bucked the trend, as Wall Street sent SYK shares up 3.8%, to $54.94, in early-afternoon trading as of about 2 p.m. today.

Stryker posted $8.31 billion in sales for 2011, 13.5% more than the $7.32 billion it brought in during 2010.

Filed Under: MassDevice Earnings Roundup, News Well, Orthopedics, Wall Street Beat Tagged With: Boston Scientific, Concentric Medical Inc., MemoMetal, Orthovita Inc., Q4, Stryker

Wright Medical details new CEO Palmisano’s deal | Personnel Moves

September 23, 2011 By MassDevice staff Leave a Comment

Wright Medical

The new CEO at Wright Medical Group Inc. (NSDQ:WMGI) will make $750,000 a year in base pay and have a shot at another $750,000 in performance bonuses, according to the terms of his deal with the orthopedic device maker.

Wright tapped Robert Palmisano, 67, to be its new chief executive earlier this week. He takes over for interim president David Stevens, who had kept watch since former CEO Gary Henley resigned suddenly after a kickbacks scandal last year.

Filed Under: News Well, Orthopedics Tagged With: AngioDynamics, Concentric Medical Inc., Executive Compensation, Kensey Nash Corp., Orthofix, Personnel Moves, Rockwell Medical Technologies, Stryker, Vasomedical Inc., wrightmedical

Concentric CEO resigns from Orthofix board citing her company’s acquisition by Stryker

September 23, 2011 By MassDevice Contributors Network Leave a Comment


8-K
1
d235398d8k.htm
FORM 8-K


Form 8-K

 


 

UNITED STATES


SECURITIES AND EXCHANGE COMMISSION

Filed Under: Uncategorized Tagged With: Concentric Medical Inc., Orthofix, Personnel Moves, Stryker

Stryker readies $750M notes offering | Wall Street Beat

September 13, 2011 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

Stryker Corp. (NYSE:SYK) is readying a $750 million debt offering of five-year senior notes, little more than a week after inking a $135 million deal to acquire Concentric Medical Inc.

The Kalamazoo, Mich.-based orthopedics giant issued another massive round of debt notes early last year, offering $500 million in 5-year notes and $500 million in 10-year notes.

Filed Under: News Well, Wall Street Beat Tagged With: BlackRock Inc., Concentric Medical Inc., Debt Financing, Fujifilm, Hansen Medical Inc., iCad Inc., Intuitive Surgical, Stryker

No recall for breast implants, BRIC markets go flat, Stryker acquires Concentric Medical for $135 | MassDevice.com +3

September 1, 2011 By MassDevice staff Leave a Comment

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.

If you read nothing else today, make sure you’re still in the know with MassDevice +3.

Filed Under: Implants, Mergers & Acquisitions, News Well, Recalls, Wall Street Beat, Women's Health Tagged With: Concentric Medical Inc., Goldman Sachs, Stryker

  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy